| Vial description: |
ACT35 antigen, OX40L receptor, TXGP1L, TNFRSF4 |
| Category: |
primary antibody |
| Clonality: |
monoclonal |
| Raised in: |
Mouse |
| Clone: |
Ber-ACT35 |
| Form: |
pure |
| Reactivity: |
Humanrimate |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P43489 |
| Application: |
F |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
CD134 / TNFRSF4 |
| Short name: |
anti-CD134 / TNFRSF4 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
member 4 (Antibody to), antibody to-CD134 / tumor necrosis factor receptor superfamily |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ACT35 and CD134 and IMD16 and OX40 and TXGP1L, Cell surfaces, DNA-templated and biological process this GO :0050710 and negative regulation of cytokine secretion and biological process this GO :0051024 and positive regulation of immunoglobulin secretion and biological process, TNFRSF4 and IDBG-635323 and ENSBTAG00000015635 and 528782, TNFRSF4 and IDBG-84605 and ENSG00000186827 and 7293, Tnfrsf4 and IDBG-208242 and ENSMUSG00000029075 and 22163, member 4, protein binding, this GO :0005031 and tumor necrosis factor-activated receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0006968 and cellular defense response and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0009986 and cell surface and cellular component this GO :0030890 and positive regulation of B cell proliferation and biological process this GO :0033209 and tumor necrosis factor-mediated signaling pathway and biological process this GO :0042098 and T cell proliferation and biological process this GO :0042981 and regulation of apoptotic process and biological process this GO :0043433 and negative regulation of sequence-specific DNA binding transcription factor activity and biological process this GO :0045859 and regulation of protein kinase activity and biological process this GO :0045892 and negative regulation of transcription, this GO :0005031 : tumor necrosis factor-activated receptor activity, this GO :0005031 : tumor necrosis factor-activated receptor activity and also this GO :0005515 : protein binding, this GO :0005515 : protein binding, tumor necrosis factor receptor superfamily |
| Identity: |
11918 |
| Gene: |
TNFRSF4 |
More about : TNFRSF4 |
| Long gene name: |
TNF receptor superfamily member 4 |
| Synonyms gene: |
TXGP1L |
| Synonyms gene name: |
member 4 , tumor necrosis factor receptor superfamily |
| Synonyms: |
ACT35 OX40 CD134 |
| Locus: |
1p36, 33 |
| Discovery year: |
1994-12-15 |
| GenBank acession: |
X75962 |
| Entrez gene record: |
7293 |
| Pubmed identfication: |
7510240 2828930 |
| Classification: |
CD molecules Tumor necrosis factor receptor superfamily |
| Havana BLAST/BLAT: |
OTTHUMG00000001415 |